Crescent Biopharma, Inc. (CBIO)

Last Closing Price: 12.96 (2025-07-11)

Beginning Cash (Quarterly)

Beginning Cash: The amount of cash reported by the company on its previous statement.

Crescent Biopharma, Inc. (CBIO) had Beginning Cash of $10.72M for the most recently reported fiscal quarter, ending 2025-03-31.

Figures for fiscal quarter ending 2025-03-31
Income Statement Financials
--
$-2.34M
--
--
$2.40M
$-2.40M
$0.06M
$-2.34M
$-2.34M
$-2.34M
$-2.34M
$-2.34M
$-2.34M
$-2.40M
$-2.40M
0.65M
0.65M
$-4.00
$-4.00
Balance Sheet Financials
$5.99M
--
--
$5.99M
$2.62M
--
--
$2.62M
$3.38M
$3.38M
$3.38M
0.65M
Cash Flow Statement Financials
$-5.11M
$0.00M
$0.00M
Beginning Cash
$10.72M
$5.61M
$-5.11M
$0.41M
--
--
Fundamental Metrics & Ratios
2.29
--
--
--
--
--
--
--
--
--
--
$-5.11M
--
--
--
--
--
--
--
-69.44%
-69.44%
-39.11%
-69.44%
$5.23
$-7.91
$-7.91